Most patients begin noticing improvements in body composition within four to eight weeks of consistent use
Tirzepatide acts as a dual GLP-1/GIP agonist, reducing appetite and improving glycemic regulation
Body Composition Changes: More significant changes, such as a reduction in body fat or noticeable weight loss, typically occur over a period of 48 weeks
If injection frequency is a concern, MK-677 remains viable, but expect to fight more food cravings
Vitamin B12 is an essential vitamin that plays an important role in cell reproduction, blood formation, metabolism of fat and carbohydrates, and protein synthesis
One of the concerns with GLP-1 therapy is muscle loss